Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients.
Liu G, Zhu J, Yu M, Cai C, Zhou Y, Yu M, Fu Z, Gong Y, Yang B, Li Y, Zhou Q, Lin Q, Ye H, Ye L, Zhao X, Li Z, Chen R, Han F, Tang C, Zeng B.
Liu G, et al. Among authors: han f.
J Transl Med. 2015 May 7;13:144. doi: 10.1186/s12967-015-0500-6.
J Transl Med. 2015.
PMID: 25947346
Free PMC article.